The analysis suggests increased expression of CD8+ T-cell, DC, and Treg function genes in 3 × 5 Gy RT-treated tumours compared to controls (Fig. S9), suggesting “early” anti-tumour immunogenic effects post-RT in MyC-CaP as seen in TRAMP-C1. The gene discussed is MYC; the disease is neoplasm.